FPI / October 4, 2019 More than 6,000 deaths have been linked to a puberty-blocking drug which is increasingly being given to children who claim to be transgender, the Food and Drug administration (FDA) reported. The FDA between 2013 and June 2019 reported 41,213 adverse events, including 6,379 deaths and 25,645 “serious” reactions in patients […]
Sign in below or Subscribe Now to see full content.
Login
